Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

The TOR Kinase Inhibitor INK128 Is Effective in Pre-B Acute Lymphoblastic Leukemia Models

David A Fruman, PhD, Matthew Robert Janes, MPH, Sharmila Mallya, MS, Collin C Vu, MD, Marie P. Shieh, MD, Michael B. Lilly, MD, Leonard S Sender, MD, Michael B Martin, PhD, Pingda Ren, PhD, Yi Liu, PhD, Christian Rommel, PhD

Blood (2011) 118 (21): 2585.

https://doi.org/10.1182/blood.V118.21.2585.2585

Published: 2011

Journal Articles

A Novel Role of Pim Serine/Threonine Kinases in Hematopoiesis: Pim 1 Kinase Increases Hematopoietic Stem Cell Population

Yingwei Lin, MD., PhD., Ningfei An, PhD., Angen Liu, PhD., Michael B. Lilly, MD, Andrew Kraft, MD, Yubin Kang, MD.

Blood (2011) 118 (21): 561.

https://doi.org/10.1182/blood.V118.21.561.561

Published: 2011

Journal Articles

Dasatinib 140 Mg Once Daily (QD) Has Equivalent Efficacy and Improved Safety Compared with 70 Mg Twice Daily (BID) in Patients with Imatinib-Resistant or -Intolerant Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): 2-Year Data from CA180- 035

Richard A. Larson, MD, Oliver G. Ottmann, MD, Neil P. Shah, MD, PhD, Michael B. Lilly, MD, Josy M. Reiffers, Aude Charbonnier, Gerhard Ehninger, MD, M. Brigid Bradley-Garelik, Chao Zhu, Giovanni Martinelli, MD

Blood (2008) 112 (11): 2926.

https://doi.org/10.1182/blood.V112.11.2926.2926

Published: 2008

Journal Articles

Use of a Homology Model of the PIM-1 Kinase To Identify Variant Flavonoids Having Selective Inhibitory Activity Against PIM-1.

Michael B. Lilly, MD, Sheldon Holder, Marina Zemskova, PhD, Jonathan Neidigh, PhD

Blood (2004) 104 (11): 2566.

https://doi.org/10.1182/blood.V104.11.2566.2566

Published: 2004

Journal Articles

R-Flurbiprofen, a Non-Steroidal Anti-Inflammatory Agent (NSAID) with Anti-Tumor Activity, Inhibits the Stromal-Induced Upregulation of Interleukin-8 in Chronic Lymphocytic Leukemia Cells.

Michael B. Lilly, MD, Jesus Berdeja, MD, C.S. Chen, MD, PhD, Svetlana Bashkyrova, Marina Zemskova, PhD

Blood (2004) 104 (11): 4794.

https://doi.org/10.1182/blood.V104.11.4794.4794

Published: 2004

Journal Articles

Expression of Cyclooxygenase-2 (COX-2) in Human Leukemias and Hematopoietic Cells.

Michael B. Lilly, MD, Leslie Drapiza, Milan Sheth, MD, Marina Zemskova, Svetlana Bashkirova, Joan Morris, MD

Blood (2004) 104 (11): 4336.

https://doi.org/10.1182/blood.V104.11.4336.4336

Published: 2004

Journal Articles

Distinct domains of the human granulocyte-macrophage colony-stimulating factor receptor α subunit mediate activation of Jak/Stat signaling and differentiation

Michael B. Lilly, Marina Zemskova, Arthur E. Frankel, Jonathan Salo, Andrew S. Kraft

Blood (2001) 97 (6): 1662–1670.

https://doi.org/10.1182/blood.V97.6.1662

Published: 2001

NARROW

The TOR Kinase Inhibitor INK128 Is Effective in Pre-B Acute Lymphoblastic Leukemia Models

A Novel Role of Pim Serine/Threonine Kinases in Hematopoiesis: Pim 1 Kinase Increases Hematopoietic Stem Cell Population

Dasatinib 140 Mg Once Daily (QD) Has Equivalent Efficacy and Improved Safety Compared with 70 Mg Twice Daily (BID) in Patients with Imatinib-Resistant or -Intolerant Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): 2-Year Data from CA180- 035

Use of a Homology Model of the PIM-1 Kinase To Identify Variant Flavonoids Having Selective Inhibitory Activity Against PIM-1.

R-Flurbiprofen, a Non-Steroidal Anti-Inflammatory Agent (NSAID) with Anti-Tumor Activity, Inhibits the Stromal-Induced Upregulation of Interleukin-8 in Chronic Lymphocytic Leukemia Cells.

Expression of Cyclooxygenase-2 (COX-2) in Human Leukemias and Hematopoietic Cells.

Distinct domains of the human granulocyte-macrophage colony-stimulating factor receptor α subunit mediate activation of Jak/Stat signaling and differentiation

Email alerts

ASH Publications

American Society of Hematology

The TOR Kinase Inhibitor INK128 Is Effective in Pre-B Acute Lymphoblastic Leukemia Models

A Novel Role of Pim Serine/Threonine Kinases in Hematopoiesis: Pim 1 Kinase Increases Hematopoietic Stem Cell Population

Dasatinib 140 Mg Once Daily (QD) Has Equivalent Efficacy and Improved Safety Compared with 70 Mg Twice Daily (BID) in Patients with Imatinib-Resistant or -Intolerant Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): 2-Year Data from CA180- 035

Use of a Homology Model of the PIM-1 Kinase To Identify Variant Flavonoids Having Selective Inhibitory Activity Against PIM-1.

R-Flurbiprofen, a Non-Steroidal Anti-Inflammatory Agent (NSAID) with Anti-Tumor Activity, Inhibits the Stromal-Induced Upregulation of Interleukin-8 in Chronic Lymphocytic Leukemia Cells.

Expression of Cyclooxygenase-2 (COX-2) in Human Leukemias and Hematopoietic Cells.

Distinct domains of the human granulocyte-macrophage colony-stimulating factor receptor α subunit mediate activation of Jak/Stat signaling and differentiation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only